The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Computational Medicine and Drug Designing Software Market Research Report 2025
Synopsis
The global Computational Medicine and Drug Designing Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Computational Medicine and Drug Designing Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computational Medicine and Drug Designing Software.
Report Scope
The Computational Medicine and Drug Designing Software market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Computational Medicine and Drug Designing Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Computational Medicine and Drug Designing Software companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Entelos
Crown Bioscience
Chemical Computing Group
Nimbus Therapeutics
Schrodinger
Dassault Systemes
Genedata
Biognos
Leadscope
Rhenovia Pharma Limited
Compugen
Certara LP
Prosarix
Simulations Plus
Strand Life Sciences
Segment by Type
Cloud-based
On-premise
Segment by Application
Drug Discovery and Development
Computational Physiological Medicine
Disease Modeling
Medical Imaging
Predictive Analysis of Drug Targets
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Computational Medicine and Drug Designing Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Computational Medicine and Drug Designing Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Computational Medicine and Drug Designing Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computational Medicine and Drug Designing Software.
Report Scope
The Computational Medicine and Drug Designing Software market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Computational Medicine and Drug Designing Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Computational Medicine and Drug Designing Software companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Entelos
Crown Bioscience
Chemical Computing Group
Nimbus Therapeutics
Schrodinger
Dassault Systemes
Genedata
Biognos
Leadscope
Rhenovia Pharma Limited
Compugen
Certara LP
Prosarix
Simulations Plus
Strand Life Sciences
Segment by Type
Cloud-based
On-premise
Segment by Application
Drug Discovery and Development
Computational Physiological Medicine
Disease Modeling
Medical Imaging
Predictive Analysis of Drug Targets
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Computational Medicine and Drug Designing Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Computational Medicine and Drug Designing Software Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cloud-based
1.2.3 On-premise
1.3 Market by Application
1.3.1 Global Computational Medicine and Drug Designing Software Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Discovery and Development
1.3.3 Computational Physiological Medicine
1.3.4 Disease Modeling
1.3.5 Medical Imaging
1.3.6 Predictive Analysis of Drug Targets
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Computational Medicine and Drug Designing Software Market Perspective (2019-2030)
2.2 Computational Medicine and Drug Designing Software Growth Trends by Region
2.2.1 Global Computational Medicine and Drug Designing Software Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Computational Medicine and Drug Designing Software Historic Market Size by Region (2019-2024)
2.2.3 Computational Medicine and Drug Designing Software Forecasted Market Size by Region (2025-2030)
2.3 Computational Medicine and Drug Designing Software Market Dynamics
2.3.1 Computational Medicine and Drug Designing Software Industry Trends
2.3.2 Computational Medicine and Drug Designing Software Market Drivers
2.3.3 Computational Medicine and Drug Designing Software Market Challenges
2.3.4 Computational Medicine and Drug Designing Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Computational Medicine and Drug Designing Software Players by Revenue
3.1.1 Global Top Computational Medicine and Drug Designing Software Players by Revenue (2019-2024)
3.1.2 Global Computational Medicine and Drug Designing Software Revenue Market Share by Players (2019-2024)
3.2 Global Computational Medicine and Drug Designing Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Computational Medicine and Drug Designing Software Revenue
3.4 Global Computational Medicine and Drug Designing Software Market Concentration Ratio
3.4.1 Global Computational Medicine and Drug Designing Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Computational Medicine and Drug Designing Software Revenue in 2023
3.5 Computational Medicine and Drug Designing Software Key Players Head office and Area Served
3.6 Key Players Computational Medicine and Drug Designing Software Product Solution and Service
3.7 Date of Enter into Computational Medicine and Drug Designing Software Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Computational Medicine and Drug Designing Software Breakdown Data by Type
4.1 Global Computational Medicine and Drug Designing Software Historic Market Size by Type (2019-2024)
4.2 Global Computational Medicine and Drug Designing Software Forecasted Market Size by Type (2025-2030)
5 Computational Medicine and Drug Designing Software Breakdown Data by Application
5.1 Global Computational Medicine and Drug Designing Software Historic Market Size by Application (2019-2024)
5.2 Global Computational Medicine and Drug Designing Software Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Computational Medicine and Drug Designing Software Market Size (2019-2030)
6.2 North America Computational Medicine and Drug Designing Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Computational Medicine and Drug Designing Software Market Size by Country (2019-2024)
6.4 North America Computational Medicine and Drug Designing Software Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Computational Medicine and Drug Designing Software Market Size (2019-2030)
7.2 Europe Computational Medicine and Drug Designing Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Computational Medicine and Drug Designing Software Market Size by Country (2019-2024)
7.4 Europe Computational Medicine and Drug Designing Software Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Computational Medicine and Drug Designing Software Market Size (2019-2030)
8.2 Asia-Pacific Computational Medicine and Drug Designing Software Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Region (2019-2024)
8.4 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Computational Medicine and Drug Designing Software Market Size (2019-2030)
9.2 Latin America Computational Medicine and Drug Designing Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Computational Medicine and Drug Designing Software Market Size by Country (2019-2024)
9.4 Latin America Computational Medicine and Drug Designing Software Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Computational Medicine and Drug Designing Software Market Size (2019-2030)
10.2 Middle East & Africa Computational Medicine and Drug Designing Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country (2019-2024)
10.4 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Entelos
11.1.1 Entelos Company Detail
11.1.2 Entelos Business Overview
11.1.3 Entelos Computational Medicine and Drug Designing Software Introduction
11.1.4 Entelos Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.1.5 Entelos Recent Development
11.2 Crown Bioscience
11.2.1 Crown Bioscience Company Detail
11.2.2 Crown Bioscience Business Overview
11.2.3 Crown Bioscience Computational Medicine and Drug Designing Software Introduction
11.2.4 Crown Bioscience Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.2.5 Crown Bioscience Recent Development
11.3 Chemical Computing Group
11.3.1 Chemical Computing Group Company Detail
11.3.2 Chemical Computing Group Business Overview
11.3.3 Chemical Computing Group Computational Medicine and Drug Designing Software Introduction
11.3.4 Chemical Computing Group Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.3.5 Chemical Computing Group Recent Development
11.4 Nimbus Therapeutics
11.4.1 Nimbus Therapeutics Company Detail
11.4.2 Nimbus Therapeutics Business Overview
11.4.3 Nimbus Therapeutics Computational Medicine and Drug Designing Software Introduction
11.4.4 Nimbus Therapeutics Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.4.5 Nimbus Therapeutics Recent Development
11.5 Schrodinger
11.5.1 Schrodinger Company Detail
11.5.2 Schrodinger Business Overview
11.5.3 Schrodinger Computational Medicine and Drug Designing Software Introduction
11.5.4 Schrodinger Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.5.5 Schrodinger Recent Development
11.6 Dassault Systemes
11.6.1 Dassault Systemes Company Detail
11.6.2 Dassault Systemes Business Overview
11.6.3 Dassault Systemes Computational Medicine and Drug Designing Software Introduction
11.6.4 Dassault Systemes Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.6.5 Dassault Systemes Recent Development
11.7 Genedata
11.7.1 Genedata Company Detail
11.7.2 Genedata Business Overview
11.7.3 Genedata Computational Medicine and Drug Designing Software Introduction
11.7.4 Genedata Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.7.5 Genedata Recent Development
11.8 Biognos
11.8.1 Biognos Company Detail
11.8.2 Biognos Business Overview
11.8.3 Biognos Computational Medicine and Drug Designing Software Introduction
11.8.4 Biognos Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.8.5 Biognos Recent Development
11.9 Leadscope
11.9.1 Leadscope Company Detail
11.9.2 Leadscope Business Overview
11.9.3 Leadscope Computational Medicine and Drug Designing Software Introduction
11.9.4 Leadscope Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.9.5 Leadscope Recent Development
11.10 Rhenovia Pharma Limited
11.10.1 Rhenovia Pharma Limited Company Detail
11.10.2 Rhenovia Pharma Limited Business Overview
11.10.3 Rhenovia Pharma Limited Computational Medicine and Drug Designing Software Introduction
11.10.4 Rhenovia Pharma Limited Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.10.5 Rhenovia Pharma Limited Recent Development
11.11 Compugen
11.11.1 Compugen Company Detail
11.11.2 Compugen Business Overview
11.11.3 Compugen Computational Medicine and Drug Designing Software Introduction
11.11.4 Compugen Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.11.5 Compugen Recent Development
11.12 Certara LP
11.12.1 Certara LP Company Detail
11.12.2 Certara LP Business Overview
11.12.3 Certara LP Computational Medicine and Drug Designing Software Introduction
11.12.4 Certara LP Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.12.5 Certara LP Recent Development
11.13 Prosarix
11.13.1 Prosarix Company Detail
11.13.2 Prosarix Business Overview
11.13.3 Prosarix Computational Medicine and Drug Designing Software Introduction
11.13.4 Prosarix Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.13.5 Prosarix Recent Development
11.14 Simulations Plus
11.14.1 Simulations Plus Company Detail
11.14.2 Simulations Plus Business Overview
11.14.3 Simulations Plus Computational Medicine and Drug Designing Software Introduction
11.14.4 Simulations Plus Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.14.5 Simulations Plus Recent Development
11.15 Strand Life Sciences
11.15.1 Strand Life Sciences Company Detail
11.15.2 Strand Life Sciences Business Overview
11.15.3 Strand Life Sciences Computational Medicine and Drug Designing Software Introduction
11.15.4 Strand Life Sciences Revenue in Computational Medicine and Drug Designing Software Business (2019-2024)
11.15.5 Strand Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Computational Medicine and Drug Designing Software Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Cloud-based
Table 3. Key Players of On-premise
Table 4. Global Computational Medicine and Drug Designing Software Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Computational Medicine and Drug Designing Software Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Computational Medicine and Drug Designing Software Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Computational Medicine and Drug Designing Software Market Share by Region (2019-2024)
Table 8. Global Computational Medicine and Drug Designing Software Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Computational Medicine and Drug Designing Software Market Share by Region (2025-2030)
Table 10. Computational Medicine and Drug Designing Software Market Trends
Table 11. Computational Medicine and Drug Designing Software Market Drivers
Table 12. Computational Medicine and Drug Designing Software Market Challenges
Table 13. Computational Medicine and Drug Designing Software Market Restraints
Table 14. Global Computational Medicine and Drug Designing Software Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Computational Medicine and Drug Designing Software Market Share by Players (2019-2024)
Table 16. Global Top Computational Medicine and Drug Designing Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Medicine and Drug Designing Software as of 2023)
Table 17. Ranking of Global Top Computational Medicine and Drug Designing Software Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Computational Medicine and Drug Designing Software Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Computational Medicine and Drug Designing Software Product Solution and Service
Table 21. Date of Enter into Computational Medicine and Drug Designing Software Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Computational Medicine and Drug Designing Software Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Computational Medicine and Drug Designing Software Revenue Market Share by Type (2019-2024)
Table 25. Global Computational Medicine and Drug Designing Software Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Computational Medicine and Drug Designing Software Revenue Market Share by Type (2025-2030)
Table 27. Global Computational Medicine and Drug Designing Software Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Computational Medicine and Drug Designing Software Revenue Market Share by Application (2019-2024)
Table 29. Global Computational Medicine and Drug Designing Software Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Computational Medicine and Drug Designing Software Revenue Market Share by Application (2025-2030)
Table 31. North America Computational Medicine and Drug Designing Software Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Computational Medicine and Drug Designing Software Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Computational Medicine and Drug Designing Software Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Computational Medicine and Drug Designing Software Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Computational Medicine and Drug Designing Software Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Computational Medicine and Drug Designing Software Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Computational Medicine and Drug Designing Software Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Computational Medicine and Drug Designing Software Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Computational Medicine and Drug Designing Software Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Computational Medicine and Drug Designing Software Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Computational Medicine and Drug Designing Software Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country (2025-2030) & (US$ Million)
Table 46. Entelos Company Detail
Table 47. Entelos Business Overview
Table 48. Entelos Computational Medicine and Drug Designing Software Product
Table 49. Entelos Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)
Table 50. Entelos Recent Development
Table 51. Crown Bioscience Company Detail
Table 52. Crown Bioscience Business Overview
Table 53. Crown Bioscience Computational Medicine and Drug Designing Software Product
Table 54. Crown Bioscience Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)
Table 55. Crown Bioscience Recent Development
Table 56. Chemical Computing Group Company Detail
Table 57. Chemical Computing Group Business Overview
Table 58. Chemical Computing Group Computational Medicine and Drug Designing Software Product
Table 59. Chemical Computing Group Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)
Table 60. Chemical Computing Group Recent Development
Table 61. Nimbus Therapeutics Company Detail
Table 62. Nimbus Therapeutics Business Overview
Table 63. Nimbus Therapeutics Computational Medicine and Drug Designing Software Product
Table 64. Nimbus Therapeutics Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)
Table 65. Nimbus Therapeutics Recent Development
Table 66. Schrodinger Company Detail
Table 67. Schrodinger Business Overview
Table 68. Schrodinger Computational Medicine and Drug Designing Software Product
Table 69. Schrodinger Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)
Table 70. Schrodinger Recent Development
Table 71. Dassault Systemes Company Detail
Table 72. Dassault Systemes Business Overview
Table 73. Dassault Systemes Computational Medicine and Drug Designing Software Product
Table 74. Dassault Systemes Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)
Table 75. Dassault Systemes Recent Development
Table 76. Genedata Company Detail
Table 77. Genedata Business Overview
Table 78. Genedata Computational Medicine and Drug Designing Software Product
Table 79. Genedata Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)
Table 80. Genedata Recent Development
Table 81. Biognos Company Detail
Table 82. Biognos Business Overview
Table 83. Biognos Computational Medicine and Drug Designing Software Product
Table 84. Biognos Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)
Table 85. Biognos Recent Development
Table 86. Leadscope Company Detail
Table 87. Leadscope Business Overview
Table 88. Leadscope Computational Medicine and Drug Designing Software Product
Table 89. Leadscope Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)
Table 90. Leadscope Recent Development
Table 91. Rhenovia Pharma Limited Company Detail
Table 92. Rhenovia Pharma Limited Business Overview
Table 93. Rhenovia Pharma Limited Computational Medicine and Drug Designing Software Product
Table 94. Rhenovia Pharma Limited Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)
Table 95. Rhenovia Pharma Limited Recent Development
Table 96. Compugen Company Detail
Table 97. Compugen Business Overview
Table 98. Compugen Computational Medicine and Drug Designing Software Product
Table 99. Compugen Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)
Table 100. Compugen Recent Development
Table 101. Certara LP Company Detail
Table 102. Certara LP Business Overview
Table 103. Certara LP Computational Medicine and Drug Designing Software Product
Table 104. Certara LP Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)
Table 105. Certara LP Recent Development
Table 106. Prosarix Company Detail
Table 107. Prosarix Business Overview
Table 108. Prosarix Computational Medicine and Drug Designing Software Product
Table 109. Prosarix Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)
Table 110. Prosarix Recent Development
Table 111. Simulations Plus Company Detail
Table 112. Simulations Plus Business Overview
Table 113. Simulations Plus Computational Medicine and Drug Designing Software Product
Table 114. Simulations Plus Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)
Table 115. Simulations Plus Recent Development
Table 116. Strand Life Sciences Company Detail
Table 117. Strand Life Sciences Business Overview
Table 118. Strand Life Sciences Computational Medicine and Drug Designing Software Product
Table 119. Strand Life Sciences Revenue in Computational Medicine and Drug Designing Software Business (2019-2024) & (US$ Million)
Table 120. Strand Life Sciences Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Computational Medicine and Drug Designing Software Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Computational Medicine and Drug Designing Software Market Share by Type: 2023 VS 2030
Figure 3. Cloud-based Features
Figure 4. On-premise Features
Figure 5. Global Computational Medicine and Drug Designing Software Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Computational Medicine and Drug Designing Software Market Share by Application: 2023 VS 2030
Figure 7. Drug Discovery and Development Case Studies
Figure 8. Computational Physiological Medicine Case Studies
Figure 9. Disease Modeling Case Studies
Figure 10. Medical Imaging Case Studies
Figure 11. Predictive Analysis of Drug Targets Case Studies
Figure 12. Computational Medicine and Drug Designing Software Report Years Considered
Figure 13. Global Computational Medicine and Drug Designing Software Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Computational Medicine and Drug Designing Software Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Computational Medicine and Drug Designing Software Market Share by Region: 2023 VS 2030
Figure 16. Global Computational Medicine and Drug Designing Software Market Share by Players in 2023
Figure 17. Global Top Computational Medicine and Drug Designing Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computational Medicine and Drug Designing Software as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Computational Medicine and Drug Designing Software Revenue in 2023
Figure 19. North America Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Computational Medicine and Drug Designing Software Market Share by Country (2019-2030)
Figure 21. United States Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Computational Medicine and Drug Designing Software Market Share by Country (2019-2030)
Figure 25. Germany Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Computational Medicine and Drug Designing Software Market Share by Region (2019-2030)
Figure 33. China Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Computational Medicine and Drug Designing Software Market Share by Country (2019-2030)
Figure 41. Mexico Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Computational Medicine and Drug Designing Software Market Share by Country (2019-2030)
Figure 45. Turkey Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Computational Medicine and Drug Designing Software Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Entelos Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)
Figure 48. Crown Bioscience Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)
Figure 49. Chemical Computing Group Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)
Figure 50. Nimbus Therapeutics Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)
Figure 51. Schrodinger Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)
Figure 52. Dassault Systemes Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)
Figure 53. Genedata Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)
Figure 54. Biognos Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)
Figure 55. Leadscope Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)
Figure 56. Rhenovia Pharma Limited Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)
Figure 57. Compugen Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)
Figure 58. Certara LP Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)
Figure 59. Prosarix Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)
Figure 60. Simulations Plus Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)
Figure 61. Strand Life Sciences Revenue Growth Rate in Computational Medicine and Drug Designing Software Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
